2019
DOI: 10.1016/j.revmed.2019.10.248
|View full text |Cite
|
Sign up to set email alerts
|

TAFRO syndrome et vascularite nécrosante cutanée : une association inédite

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Hypothyroidism is a common pathology estimated at 3.1% [1]. TAFRO syndrome is rare, first described in 2010 in Japan, diagnosed as a particular form of multicentric Castleman's disease without proliferation of herpes virus type 8: HHV8, including thrombocytopenia, anasarca, fever, myelofibrosis, renal failure, and organomegaly [2]. Its correlation with hypothyroidism has been reported between elevated levels of vascular endothelial growth factor (VEGF) and TSH in patients with hypothyroidism.…”
Section: Introductionmentioning
confidence: 99%
“…Hypothyroidism is a common pathology estimated at 3.1% [1]. TAFRO syndrome is rare, first described in 2010 in Japan, diagnosed as a particular form of multicentric Castleman's disease without proliferation of herpes virus type 8: HHV8, including thrombocytopenia, anasarca, fever, myelofibrosis, renal failure, and organomegaly [2]. Its correlation with hypothyroidism has been reported between elevated levels of vascular endothelial growth factor (VEGF) and TSH in patients with hypothyroidism.…”
Section: Introductionmentioning
confidence: 99%